Latest Health Insights
A strong rehashing message of individualizing determined thought is resounded all through the American Diabetes Association’s Standards of Medical Care in Diabetes—2020 (Standards of Care) circulated today. Considering the latest legitimate diabetes look at and clinical starters, the Standards of Care joins new and revived proposition and rules for pondering people with diabetes. The Standards…
A report for the year range 2019 to 2024 has been recently published which has analyzed and forecast the current and expected status of medical imaging in the healthcare sector. Therapeutic imaging is expecting an unyieldingly huge activity in current social protection where it is used for noninvasive diagnostics, treatment orchestrating, and follow-up evaluations. The…
Today The Food and Drug Administration announced the approval of Merck & Co., Inc.’s new vaccine Ervebo which is the first and only FDA-approved safe and effective Ebola virus vaccine. Ervebo is effective for the prevention of diseases caused by Zaire ebolavirus. There are very rare cases of Ebola virus diseases (EVD) in the United…
The lung injury cases associated with vaping products and e-cigarettes are increasing day by day. Recently, a case was reported in the European Respiratory Journal in which doctors discovered another reason as to why vaping can cause lung damage. This is the first known case of an e-cigarette user who used to vape THC. The…
The new data related to early-stage breast cancer has been released and presented at San Antonio Breast Cancer Symposium (SABCS). This data shows that a woman doesn’t need any other way like chemotherapy because of the test MammaPrint 70-gene assay is more effective and useful. This announced data has been compared with the genomic profiling…
JDRF, the fundamental affiliation financing type 1 diabetes investigation, announced that it has submitted 23 planning grants, totaling more than $8 million in new advantages for animate best in class period of Type 1 Diabetes authorities, addressing 9 states: Australia, France, Canada, Germany, Denmark, Switzerland and the United Kingdom, in association with 20 foundations. The…
Provention Bio, Inc. which is a clinical stage biopharmaceutical association gave to blocking and envisioning insusceptible intervened ailments, detailed that it completed a Type B multidisciplinary meeting with the U.S. Food and Drug Administration to discuss the proposed substance of a Biologics License Application for teplizumab for the neutralizing activity or delay of type 1…
The European dental embed franchise is anticipated to develop at a CAGR of ~6% during the conjecture time frame 2019-2025 according to a recently published report. The market in Europe is relied upon to develop relentlessly during the estimate time frame because of developing mindfulness and expanded reception of dental reclamation. The significant driver adding…
Recent research study reveals the astounding potential of bioelectronic medicine to treat pulmonary hypertension. This study is performed by the research team from Feinstein Institutes for Medical Research and is now published in the journal “Springer Nature’s Bioelectronic Medicine”. Click here to read the complete study findings. This research has been carried out by a team…
The U.S. Food and Drug Administration recently authorized the marketing of a newly developed test for the diagnosis of Methicillin-resistant Staphylococcus aureus (MRSA) to Roche Molecular Systems Inc, which is a company that develops medical equipment for the purpose of research. The test uses advanced technology and bacterial viability to detect any colonization of MRSA….